Dynamic adsorption properties of n-alkyl glucopyranosides determine their ability to inhibit cytolysis mediated by acoustic cavitation.
Suspensions of human leukemia (HL-60) cells readily undergo cytolysis when exposed to ultrasound above the acoustic cavitation threshold. However, n-alkyl glucopyranosides (hexyl, heptyl, and octyl) completely inhibit ultrasound-induced (1057 kHz) cytolysis (Sostaric, et al. Free Radical Biol. Med. 2005, 39, 1539-1548). The efficacy of protection from ultrasound-induced cytolysis was determined by the n-alkyl chain length of the glucopyranosides, indicating that protection efficacy depended on adsorption of n-alkyl glucopyranosides to the gas/solution interface of cavitation bubbles and/or the lipid membrane of cells. The current study tests the hypothesis that "sonoprotection" (i.e., protection of cells from ultrasound-induced cytolysis) in vitro depends on the adsorption of glucopyranosides at the gas/solution interface of cavitation bubbles. To test this hypothesis, the effect of ultrasound frequency (from 42 kHz to 1 MHz) on the ability of a homologous series of n-alkyl glucopyranosides to protect cells from ultrasound-induced cytolysis was investigated. It is expected that ultrasound frequency will affect sonoprotection ability since the nature of the cavitation bubble field will change. This will affect the relative importance of the possible mechanisms for ultrasound-induced cytolysis. Additionally, ultrasound frequency will affect the lifetime and rate of change of the surface area of cavitation bubbles, hence the dynamically controlled adsorption of glucopyranosides to their surface. The data support the hypothesis that sonoprotection efficiency depends on the ability of glucopyranosides to adsorb at the gas/solution interface of cavitation bubbles.
Sostaric
Joe Z
JZ
Radiation Biology Branch, Center for Cancer Research, National Cancer Institute/NIH, Bethesda, MD 20892, USA. sostaric.2@osu.edu
Miyoshi
Norio
N
Cheng
Jason Y
JY
Riesz
Peter
P
D000162:Acoustics; D000327:Adsorption; D000478:Alkylation; D005947:Glucose / Q000737:chemistry*
D005947:Glucose
Ultrason Sonochem. 1997 Apr;4(2):127-30
11237029
J Phys Chem B. 2008 Jan 24;112(3):852-8
18085771
Expert Rev Mol Diagn. 2006 May;6(3):493-502
16706749
Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Apr;65(4 Pt 2B):046310
12006016
Free Radic Biol Med. 2005 Dec 15;39(12):1539-48
16298679
J Am Chem Soc. 2001 Nov 7;123(44):11010-9
11686706
Adv Colloid Interface Sci. 2000 Feb 1;85(1):61-97
10696449
Ultrasound Med Biol. 2004 Jun;30(6):827-40
15219962
J Natl Cancer Inst. 1982 Jul;69(1):131-6
6954305
Ultrason Sonochem. 2007 Apr;14(4):438-44
17218145
Ultrasound Med Biol. 2006 Jun;32(6):915-24
16785013
J Am Chem Soc. 2007 May 9;129(18):6031-6
17439213
Free Radic Biol Med. 2003 Mar 15;34(6):710-9
12633748
Curr Pharm Biotechnol. 2007 Dec;8(6):355-61
18289044
Ultrasound Med Biol. 1983 Nov-Dec;9(6):629-33
6670148
Adv Colloid Interface Sci. 2001 Jan 29;89-90:423-38
11215808
Adv Colloid Interface Sci. 2000 Mar 31;85(2-3):103-44
10768479
Ultrasound Med Biol. 1998;24 Suppl 1:S11-21
9841460
Ann N Y Acad Sci. 2000;899:335-48
10863551
J Phys Chem B. 2005 Sep 29;109(38):17799-801
16853282
J Am Chem Soc. 2004 Mar 10;126(9):2755-62
14995192
J Am Chem Soc. 2008 Mar 19;130(11):3248-9
18302375
J Phys Chem B. 2007 Feb 15;111(6):1361-7
17249713
Pharm Res. 2002 Aug;19(8):1160-9
12240942
J Pharm Sci. 2002 Feb;91(2):444-53
11835204
Ultrason Sonochem. 2007 Apr;14(4):470-5
17234444
J Pharm Sci. 2003 Jun;92(6):1138-46
12761803
Nature. 2003 May 8;423(6936):153-6
12736680
Chem Commun (Camb). 2002 Aug 21;(16):1740-1
12196976
Anal Biochem. 1980 Feb;102(1):68-71
6243887
J Am Chem Soc. 2007 Feb 28;129(8):2250-8
17279753
Ultrasound Med Biol. 2004 Oct;30(10):1263-7
15582225
J Acoust Soc Am. 1998 Feb;103(2):1183-9
9479770
Ultrasound Med Biol. 1996;22(4):497-514
8795177